Xiuwen Guan

In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China

Yiqun Li, Nilupai Abudureheiyimu, Hongnan Mo et al. · Frontiers in Oncology · 2022 · 118 citations · Full text

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

Xiuwen Guan, Fei Ma, Chunxiao Li et al. · Cancer Communications · 2019 · 113 citations · Full text

ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy

Fei Ma, Wenjie Zhu, Yanfang Guan et al. · Oncotarget · 2016 · 94 citations · Full text

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial

Qiao Li, Xiuwen Guan, Shanshan Chen et al. · Clinical Cancer Research · 2019 · 89 citations

Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer

Fei Ma, Yanfang Guan, Zongbi Yi et al. · International Journal of Cancer · 2019 · 88 citations